| | | | | |
RNAC Cartesian Therapeutics, Inc. Common Stock | €8,9758 | +4,03% | €272,21M | €3,28K | |
FUND Sprott Focus Trust, Inc. | €9,2812 | +0,10% | €272,05M | €2,60K | |
FATE Fate Therapeutics, Inc. | €2,1357 | +2,05% | €271,92M | €99,26K | |
NMRA Neumora Therapeutics, Inc. Common Stock | €1,3337 | +1,97% | €271,75M | €25,38K | |
GALT Galectin Therapeutics Inc. | €3,3545 | +0,80% | €271,60M | €28,52K | |
NREF NexPoint Real Estate Finance, Inc. | €14,9111 | -1,17% | €271,58M | €869,70 | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | €9,3146 | +0,28% | €271,33M | €2,573 | |
PSBD Palmer Square Capital BDC Inc. | €8,8720 | -0,35% | €271,30M | €2,98K | |
| €3,0714 | +15,15% | €271,11M | €388,64K | |
| €5,7080 | +3,50% | €270,93M | €10,43K | |
SMTI Sanara MedTech Inc. Common Stock | €29,4551 | -0,11% | €270,68M | €16,21K | |
MLP Maui Land & Pineapple Co. | €13,6837 | +1,23% | €270,65M | €18,01 | |
AFB Alliance National Municipal Income Fund, Inc. | €9,3704 | -0,05% | €270,46M | €7,06K | |
| €34,9959 | -0,46% | €270,43M | €174,97 | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | €9,0359 | +0,04% | €270,43M | €16,33K | |
